Peroxisome proliferator-activated receptor δ is a specific sensor for teratogenic valproic acid derivatives

This publication has 30 references indexed in Scilit:

• Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre
  European Journal of Pharmacology, 1998
• The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
  The Journal of Steroid Biochemistry and Molecular Biology, 1998
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
  Proceedings of the National Academy of Sciences, 1997
• Possible Mechanisms of Valproate in Migraine Prophylaxis
  Cephalalgia, 1997
• Further Branching of Valproate-Related Carboxylic Acids Reduces the Teratogenic Activity, but Not the Anticonvulsant Effect
  Chemical Research in Toxicology, 1996
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
  Endocrinology, 1996
• Anticonvulsant and Neurotoxic Activities of Twelve Analogues of Valproic Acid
  Journal of Pharmaceutical Sciences, 1993
• Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: Distinct differences in morphology and periods of sensitivity
  Teratology, 1992
• Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.
  Proceedings of the National Academy of Sciences, 1992
• The Enantiomers of the Valproic Acid Analogue 2-n-Propyl-4-pentynoic Acid (4-yn-VPA): Asymmetric Synthesis and Highly Stereoselective Teratogenicity in Mice
  Pharmaceutical Research, 1992